Alumis Inc. income statement

In fiscal 2025, Alumis Inc. reported revenue of $24.1m, operating income of −$454m (a -1886.9% margin) and net income of −$243m, or −$2.86 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Alumis Inc.: income statement, annual
Fiscal year	2025Dec 2025	LTMJun 2026
Revenue	24	7
Research and development	386	347
General and administrative	92	77
Operating income	−454	−459
Income before tax	−252	—
Income tax	−9	—
Net income	−243	−439
Diluted EPS	−$2.86	−$3.90
Diluted shares (average)	85m	113m
EBITDA	−450	−456

US$ millions unless shown otherwise. Fiscal quarters.

Alumis Inc.: income statement, quarterly
Quarter	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	17	3	2	2	2	2
Research and development	97	109	98	83	82	85
General and administrative	22	34	20	16	19	23
Operating income	−102	−141	−115	−96	−98	−149
Income before tax	—	51	−111	−93	—	−144
Income tax	—	−9	0	0	—	−2
Net income	−99	59	−111	−93	−93	−142
Diluted EPS	−$1.82	$0.77	−$1.06	−$0.94	−$0.74	−$1.11
EBITDA	−101	−140	−114	−96	−98	−148

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ALMS vs EVAX ALMS vs ROIV ADAG vs ALMS

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Alumis Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Alumis Inc.